Romania · Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 6.49 billion. The enterprise value is 8.32 billion.
| Market Cap | 6.49B |
| Enterprise Value | 8.32B |
Important Dates
The last earnings date was Monday, March 30, 2026.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 530.82 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 530.82M |
| Shares Outstanding | 530.82M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.47% |
| Owned by Institutions (%) | 15.88% |
| Float | 337.25M |
Valuation Ratios
The trailing PE ratio is 575.71 and the forward PE ratio is 55.55.
| PE Ratio | 575.71 |
| Forward PE | 55.55 |
| PS Ratio | 2.04 |
| PB Ratio | 11.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1,842.96 |
| P/OCF Ratio | 29.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.60, with an EV/FCF ratio of 2,362.90.
| EV / Earnings | 738.14 |
| EV / Sales | 2.62 |
| EV / EBITDA | 18.60 |
| EV / EBIT | 51.56 |
| EV / FCF | 2,362.90 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 3.46.
| Current Ratio | 0.79 |
| Quick Ratio | 0.55 |
| Debt / Equity | 3.46 |
| Debt / EBITDA | 4.32 |
| Debt / FCF | 548.73 |
| Interest Coverage | 1.81 |
Financial Efficiency
Return on equity (ROE) is -0.72% and return on invested capital (ROIC) is -1.44%.
| Return on Equity (ROE) | -0.72% |
| Return on Assets (ROA) | 3.21% |
| Return on Invested Capital (ROIC) | -1.44% |
| Return on Capital Employed (ROCE) | 6.79% |
| Weighted Average Cost of Capital (WACC) | 5.49% |
| Revenue Per Employee | 470,569 |
| Profits Per Employee | 1,671 |
| Employee Count | 6,962 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 10.83 |
Taxes
In the past 12 months, Med Life has paid 22.99 million in taxes.
| Income Tax | 22.99M |
| Effective Tax Rate | 120.12% |
Stock Price Statistics
The stock price has increased by +100.00% in the last 52 weeks. The beta is 0.57, so Med Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +100.00% |
| 50-Day Moving Average | 12.21 |
| 200-Day Moving Average | 9.82 |
| Relative Strength Index (RSI) | 50.41 |
| Average Volume (20 Days) | 106,151 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 3.17 billion and earned 11.27 million in profits. Earnings per share was 0.02.
| Revenue | 3.17B |
| Gross Profit | 1.54B |
| Operating Income | 161.31M |
| Pretax Income | 19.14M |
| Net Income | 11.27M |
| EBITDA | 344.58M |
| EBIT | 161.31M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 176.18 million in cash and 1.93 billion in debt, with a net cash position of -1.76 billion or -3.31 per share.
| Cash & Cash Equivalents | 176.18M |
| Total Debt | 1.93B |
| Net Cash | -1.76B |
| Net Cash Per Share | -3.31 |
| Equity (Book Value) | 558.82M |
| Book Value Per Share | 0.91 |
| Working Capital | -182.56M |
Cash Flow
In the last 12 months, operating cash flow was 222.70 million and capital expenditures -219.18 million, giving a free cash flow of 3.52 million.
| Operating Cash Flow | 222.70M |
| Capital Expenditures | -219.18M |
| Depreciation & Amortization | 183.27M |
| Net Borrowing | 86.95M |
| Free Cash Flow | 3.52M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 48.51%, with operating and profit margins of 5.08% and 0.36%.
| Gross Margin | 48.51% |
| Operating Margin | 5.08% |
| Pretax Margin | 0.60% |
| Profit Margin | 0.36% |
| EBITDA Margin | 10.86% |
| EBIT Margin | 5.08% |
| FCF Margin | 0.11% |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 0.17% |
| FCF Yield | 0.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 1.94 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.94 |
| Piotroski F-Score | 6 |